Skip to content

Insider · CIK 0001884671

Deborah M. Autor

director

Files at AMRX (Amneal Pharmaceuticals, Inc.), HIMS (Hims & Hers Health, Inc.). First filing Nov 25, 2024, latest Nov 25, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $334k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

AMRX: Amneal Pharmaceuticals, Inc.

AMRXOct 9, 2026 · close 19.91

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
55Moderate
AMRXsell 3
Amneal Pharmaceuticals, Inc.
$334k
40,000 shares
-43%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 12, 2025HIMS
Hims & Hers Health, Inc.
MOption exercise
Class A Common Stock
+6,175--6,175Jun 16, 2025
Jun 12, 2025HIMS
Hims & Hers Health, Inc.
MOption exercise
Restricted Stock Unitderivative
-6,175$0.00$00Jun 16, 2025
May 5, 2025AMRX
Amneal Pharmaceuticals, Inc.
MOption exercise
Class A Common Stock
+40,258--93,660May 8, 2025
May 5, 2025AMRX
Amneal Pharmaceuticals, Inc.
MOption exercise
Restricted Stock Unitsderivative
-40,258$0.00$00May 8, 2025
May 6, 2025AMRX
Amneal Pharmaceuticals, Inc.
AGrant or award
Restricted Stock Unitsderivative
+34,819$0.00$034,819May 8, 2025
Nov 21, 2024AMRX
Amneal Pharmaceuticals, Inc.
SOpen-market sale
Class A Common Stock
-6,771$8.41$57k86,631Nov 25, 2024
Nov 22, 2024AMRX
Amneal Pharmaceuticals, Inc.
SOpen-market sale
Class A Common Stock
-33,229$8.34$277k53,402Nov 25, 2024
Nov 15, 2024HIMS
Hims & Hers Health, Inc.
AGrant or award
Restricted Stock Unitderivative
+21,164$0.00$021,164Nov 19, 2024
Nov 15, 2024HIMS
Hims & Hers Health, Inc.
AGrant or award
Restricted Stock Unitderivative
+6,175$0.00$06,175Nov 19, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Deborah M. Autor: insider trades and track record | InsiderTell